METHODS OF MAKING SUSTAINED RELEASE FORMULATIONS OF OXYMORPHONE RELATED APPLICATIONS

Details for Australian Patent Application No. 2002318210 (hide)

Owner PENWEST PHARMACEUTICALS COMPANY

Inventors BAICHWAL, Anand, R.; KAO, HuaiHung; MCCALL, Troy, W.

Pub. Number AU-A-2002318210

PCT Number PCT/US02/21354

PCT Pub. Number WO2003/004029

Priority 60/303,357 06.07.01 US; 60/329,426 15.10.01 US; 60/329,352 15.10.01 US

Filing date 3 July 2002

Wipo publication date 21 January 2003

International Classifications

A61K 031/485 - Morphinan derivatives, e.g. morphine, codeine

A61P 025/04 Drugs for disorders of the nervous system

A61K 009/00 Medicinal preparations characterised by special physical form

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 60/303,357 06.07.01 US; 60/329,426 15.10.01 US; 60/329,352 15.10.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-A-2002318210

8 April 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002318211-Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic

2002318209-IDENTIFICATION AND USE OF CONSERVED NONCODING SEQUENCES